Fig. 1 · Structure
Documents & Downloads
ACS14
Aspirin Derivative
ACS14 is an aspirin derivative that primarily targets biochemical pathways involved in vascular regulation. It has been shown to effectively reduce Buthionine Sulfoximine (BSO)-induced hypertension as well as plasma levels of thromboxane B2, 8-isoprostane, and insulin in rat models. ACS14 serves as a valuable tool for research into hypertension and related cardiovascular conditions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 894430-68-3 |
| Applications | Aspirin Derivative |
| Formula | C18H12O4S3 |
| Molecular Weight | 388.48 |
| SMILES | O=C(C1=C(OC(C)=O)C=CC=C1)OC2=CC=C(C(SS3)=CC3=S)C=C2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.